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 ABSTRACT 
       
This is a study about usefulness of cortical mastoidectomy in 
addition to myringoplasty for the treatment of active cases of chronic 
otitis media mucosal type , conducted in a tertiary care center between 
JAN 2012 to SEP 2013. 
    About 60 patients were selected and out of which 30 patients were 
treated with cortical mastoidectomy with myringoplasty , in another 30 
patients myringoplasty alone was done.  
Post operative results were compared at 2months , 6months and at 
1 year  in terms of graft uptake, recurrence of disease and hearing  
improvement . And the results showed that cortical mastoidectomy had 
no added advantage over myringoplasty in treating active cases of 
chronic otitis media –mucosal type. 
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INTRODUCTION 
Chronic otitis media is a chronic inflammation of the middle ear and 
mastoid cavity which presents with persistant ear discharge through a 
tympanic membrane perforation, for a period of more than 3 months. 
  Prevalence surveys show that the global burden of illness from 
chronic otitis media involves 100-300 million individuals with active ear 
discharge. 58 % of whom suffer from significant hearing loss. And a disease 
burden of 2.1 million of DALY. Over 85% of the burden is seen in 
developing nations. 
To improve the hearing, to make the discharging ear dry and to 
prevent the recurrence of disease two surgical procedures, cortical 
mastoidecmy with type 1 tympanoplasty and myringoplasty are offered by 
otologists . 
This study, conducted at department of ENT, Stanley medical college, 
discusses the effectiveness of these two surgical procedures in terms of 
hearing improvement, graft uptake, recurrence in carefully selected patients 
in active cases of chronic otitis media tubotympanic type of these two 
surgical procedures in terms of hearing improvement, graft uptake, 
recurrence in carefully selected patients in active cases of chronic otitis 
media tubotympanic type. 
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AIM OF STUDY 
 
To  compare the  efficacy  of  two surgical procedures , cortical 
mastoidectomy  with type 1  tympanoplasty   and  myringoplasty alone ,in 
active cases of tubotympanic  type of  chronic otitis media. 
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REVIEW OF LITERATURE 
DEVELOPMENT OF THE EAR 
  The human ear development begins at the fourth week of embryonic 
life. 
EXTERNAL EAR 
The auricle develops from auricular hillocks, derived from first and 
second branchial arches. The six hillocks develop in the 6-week of 
embryonic life. The external auditory meatus formed by deepening of the 
groove between the two arches. 
At the dorsal end of the first branchial groove, the ectodermal cells 
thicken and form the external meatus. These ectodermal cells proliferation 
forms a meatal “plug” that progress medially. Resorption of cells in the 
center of this meatal plug forms a tube-like structure which becomes ear 
canal.  When complete canalization fails to occur that leads to External canal 
atresia. 
MIDDLE EAR 
The middle ear cavity forms as a lateral extension of the first 
pharyngeal pouch. The proximal end of this extension becomes the 
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eustachian tube. The lateral extension joins with the ectoderm of the meatal 
plug and forms the tympanic membrane. 
From Mesoderm of the first branchial arch, the malleus, incus, 
anterior malleolar ligaments and tensor tympani muscle are derived. From 
the mesoderm of second arch, Stapes, stapedius muscle derived . 
INNER EAR 
  It has two components, 
1. Membranous labyrinth. -derived from the ectoderm 
2. Bony labyrinth- derived from the mesoderm and neural crest 
 
 
 
1. Oticplacode 
2. Otic cup 
3. Otic cyst 
4. Inner ear  
 5 
 
The membranous labyrinth develops from the otic placode which is a 
thickening of the ectoderm adjacent to the hindbrain. This otic placode 
invaginates and forms an otic cup. By the end of the fourth week, the edges 
of the otic cup fuse together form the otic vesicle/otocyst.  A few of   otic 
epithelial cells in the otic cup and otocyst separates from the epithelium and 
joins to form neurons of the eighth cranial nerve. These neurons innervate 
sensory organs within the inner ear. 
 
A diverticulum develops in the otocyst elongates to form the 
endolymphatic duct and sac. The remaining portion of the otocyst enlarges 
and forms a ventral saccular and cochlear region, and the dorsal region 
develops into the utricle and three semicircular ducts. 
 
The superior and posterior semicircular canals develop from a vertical 
outgrowth in the dorsal region of the otocyst. The lateral duct develops from 
a horizontal outgrowth in the lateral portion of the otocyst. 
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THE EXTERNAL AUDITORY CANAL: 
NORMAL ANATOMY: 
The external auditory canal is approximately 2.5 cm in length and 
serves as a channel for sound transmission to the middle ear. Its lateral one-
third is bolstered by elastic cartilage oriented in an upward and backward 
fashion; its anterior aspect is pierced by vertical fissures known as the 
fissure of Santorini. These fissures are a potential route for spread of 
infections or neoplasms between the external auditory canal and the parotid 
gland.  
The medial two-thirds of the external auditory canal is osseous and is 
oriented in a downward and forward direction. Hence the auricle must be 
pulled upward and posteriorly to achieve alignment during otoscopic 
examination. The narrowest portion of the external auditory canal or isthmus 
is located just medial to the junction of the bony and fibrocartilagenous 
canal. 
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THE TYMPANIC MEMBRANE  
 
 
The tympanic membrane is irregularly round and slightly conical in 
shape. The apex of the cone is located at the umbo, which marks the tip of 
the manubrium. In the adult, it is angulated approximately 140° with respect 
to the superior wall of the external auditory canal. The vertical diameter of 
the tympanic membrane as determined along the axis of the manubrium 
ranges from 8.5 to 10 mm, while the horizontal diameter varies from 8 to 9 
mm.  
The anterior and posterior tympanic striae extend from the lateral 
process of the malleus to the anterior and posterior tympanic spines, 
respectively. These striae divide the tympanic membrane into larger pars 
tensa below, and smaller triangular pars flaccida (or Shrapnell’s membrane) 
above.  
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The thickened periphery of the pars tensa , the tympanic annulus 
anchors the tympanic membrane in a groove known as  the tympanic sulcus. 
The tympanic annulus and sulcus are absent superiorly in the area of the 
notch of Rivinus.  
The pars tensa, as its name suggests, is taut and consists of three 
layers:  
 A lateral epidermal layer  
 A medial mucosal layer  
 An intermediate fibrous layer. 
 
The pars flaccida, first described by Shrapnell, also consists of 
epidermal, fibrous, and mucosal layers. Here, the fibrous layer is scanty and  
consists of irregularly arranged collagen and elastic fibers.  
THE OSSICLES: 
The three ossicles (malleus, incus, stapes) serve to transmit sound energy 
from the tympanic membrane to the inner ear. 
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THE MALLEUS:  
It has a head, neck, lateral process, anterior process, and manubrium.  
It is held to the walls of the petrotympanic fissure by the anterior 
malleal ligament which, with the posterior incudal ligament, serves to 
establish the axis of rotation of the ossicles. On its thinner, medial aspect 
runs the chorda tympani nerve as it passes anteriorly to enter the iter chordae 
anterius at the Glaserian fissure.  
The lateral process of the malleus contains a cartilaginous cap 
attached to the pars tensa of the tympanic membrane. The inferior end of the 
manubrium is firmly attached to the tympanic membrane as the pars propria 
splits to envelop it (the umbo).  
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The malleus is held in place by five ligaments, one articulation, the 
tensor tympani tendon, and the tympanic membrane. 
 
 Three of the five ligaments have a suspensory function. They are:  
 The anterior suspensory ligament  
 The lateral suspensory ligament  
 The superior suspensory ligament  
 
THE INCUS: 
 
The incus, the largest of the auditory ossicles, consists of a body, short 
process, long process, and lenticular process. The body of the incus rests in 
the epitympanum in association with the head of the malleus.  
The short process of the incus extends posteriorly, occupying the 
posterior incudal recess (fossa incudis).The long process reaches inferiorly, 
to end in the lenticular process; the convex surface of this process articulates 
with the concave surface of the head of the stapes.  
The long process of the incus is highly susceptible to osteitic 
resorption caused by chronic otitis media.  
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THE STAPES: 
The stapes is the smallest ossicle. It consists of a head, footplate (the 
basis stapedis), and two crura or legs. The stapedius tendon attached to the 
superior aspect of the posterior crus.  
 
 The footplate, in association with the annular ligament, seals the oval 
Window. The head articulates with the lenticular process of the incus at its 
fovea.  
THE MUSCLES  
THE STAPEDIUS MUSCLE: 
The stapedius muscle, the smallest of the skeletal muscles, emerges 
from the pyramidal eminence and attaches to the head and/or posterior crus 
of the stapes. It is supplied by facial nerve. 
 
THE TENSOR TYMPANI MUSCLE: 
The tensor tympani muscle, arises from the cartilage of the eustachian 
tube, attach to the concave surface of the cochleariform (spoon-shaped) 
process, at which point the main body of the tendon turns laterally to attach 
to the medial and anterior surfaces of the neck and the manubrium of the 
malleus. Its innervation is from the trigeminal nerve . The action of the 
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tensor tympani muscle is to draw the manubrium medially, thus tensing the 
tympanic membrane.  
 
THE MIDDLE EAR SPACES: 
The tympanic cavity is a cleft in the sagittal plane measuring about 15 
mm in the vertical and anteroposterior dimensions. 
 In its transverse dimension, it expands superiorly to 6 mm and 
inferiorly to 4 mm from a central constriction of 2 mm.  
At the floor of the tympanic cavity (jugular wall) a small plate of bone 
separates the jugular bulb. 
In the posterior wall, the chordal eminence is lateral to the pyramidal 
eminence and medial to the posterior rim of the tympanic membrane. There 
is a foramen in this eminence, known as the iter chordae posterius , through 
which the chorda tympani nerve gains access to the middle ear.  
The facial recess is interposed between the chordal eminence laterally 
and the pyramidal eminence medially and superiorly bounded by the fossa 
incudis. 
The sinus tympani lies between the ponticulus (which bridges the gap 
between the pyramidal eminence and the promontory superiorly,) and the 
subiculum . 
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 The anterior wall of the middle ear (carotid wall) narrows inferiorly 
where it is formed by the thin bony shell of the carotid canal. Located more 
superiorly in the anterior wall is the orifice of the eustachian tube and above 
it the tensor tympani muscle lies in its semicanal.  
The roof (tegmental wall, tegmen tympani) separates the tympanic 
cavity from the middle cranial fossa.  
The lateral boundary (membranous wall) is composed of the tympanic 
membrane, the bony tympanic ring, and a layer of bone from the squama - 
the scutum or shield of Leidy.  
 
 The medial wall (labyrinthine wall) of the tympanic cavity is marked 
by two main depressions : 
 The round window niche  
 The oval window niche. 
The round window niche is located anteroinferior to the subiculum and 
posteroinferior to the promontory.The latter structure is the bulge of the 
bone overlying the basal turn of the cochlea.  
The oval window niche is anterosuperior to the ponticulus . Located 
posterosuperiorly is the prominence of the facial canal as it traverses the 
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medial wall and then descends along the mastoid wall of the tympanic 
cavity.  
The middle ear space is divided into four regions:  
 The mesotympanum (middle ear proper) is that area located medial to 
the tympanic membrane and the bony tympanic annulus.  
 The epitympanum is that area that lies medial to the  pars flaccida and 
scutum. 
 The protympanum lies anterior to a frontal plane drawn through to the 
anterior margin of the tympanic annulus. It leads to the tympanic 
orifice of the eustachian tube.  
 The hypotympanum is that part of the middle ear located inferior to a 
horizontal plane through the most inferior part of the tympanic 
annulus.  
THE EUSTACHIAN TUBE: 
The eustachian tube, a mucosally lined pathway between the 
nasopharynx and the middle ear, permits ventilation of the pneumatized 
spaces of the temporal bone while safeguarding against bacterial 
contamination of these spaces. The posterolateral one-third is bony while the 
anteromedial two-thirds is fibrocartilaginous; these two sections are joined at 
the tubal isthmus. The overall length of the eustachian tube in the adult is 
36mm.  
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THE MIDDLE EAR MUCOSA: 
In electron microscopic observations, Hentzer distinguished five types 
of cells in the middle ear mucosa:  
 Nonciliated without secretory granules  
 Nonciliated with secretory granules  
 Ciliated  
 Intermediate  
 Basal  
The mucosa of the middle ear represents a modified respiratory mucosa.  
 
THE MASTOID REGION: 
At birth the mastoid has a single cavity consisting of the antrum and 
small adjacent mastoid.It occupies a superficial position and is surrounded 
by diploic bone.   
 In adult life, the normal mastoid may be fully pneumatized, 
diploic, or sclerotic. The anterolateral portion of the mastoid arises from the 
squamous part of the temporal bone; the posteromedial portion, including 
the mastoid tip, arises from the petrous part.  
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In most mastoids, the plane of junction of these two parts is marked 
internally by an incomplete plate of bone, the petrosquamosal septum, also 
known as Koerner’s septum. The mastoid antrum area is a large superior 
central space which communicates with the epitympanic space of the middle 
ear via the aditus.  
 
THE INNER EAR  
THE BONY LABYRINTH:  
The long axis of the bony labyrinth, measuring 20 mm in length, 
roughly parallels the posterior surface of the petrous pyramid. 
 Its components are the vestibule, the semicircular canals, and the cochlea.  
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THE VESTIBULE: 
The vestibule is the central chamber. At the posterosuperior aspect of 
its medial wall is a depression known as the elliptical recess which 
accommodates part of the utricular macula. 
  The spherical recess is a similar depression for the saccular macula, 
located anteroinferiorly.  The vestibular crest, is an oblique elevation 
between these two recesses. The opening for the cochlea lies anteriorly, 
while the openings for the semicircular canals are located posteriorly.  
The oval window is an opening on the lateral wall, adjoining the 
tympanic cavity. The vestibular aqueduct with its contained endolymphatic 
duct opens into the posteroinferior aspect of the vestibule.  
THE CANALS: 
The osseous semicircular canals are: 
 The lateral  
 Posterior  
 Superior canals  
  Each canal expands to double its diameter at its osseous ampulla 
where it communicates with the vestibule. The non ampullated ends of the 
posterior and superior canals fuse, forming the common crus, while the non 
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ampullated end of the lateral canal remains independent .Thus, the vestibule 
has five apertures for the semicircular canals. 
 
THE MEMBRANOUS LABYRINTH: 
The membranous labyrinth is encased within the bony labyrinth and is 
surrounded by the perilymphatic space. 
 
The constituents are  
 The cochlear duct,  
 The three semicircular ducts and their ampullae,  
 The otolithic organs (the utricle and saccule), and the endolymphatic 
(otic) duct and sac. 
 
This system of epithelially lined channels and spaces is filled with 
endolymph (Scarpa’s fluid); the utricular duct, the saccular duct, and the 
ductus reuniens interconnect the major structures. 
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COCHLEA 
 
The cochlea is snail shaped and has a spiral configuration with two 
and a half turns. The center portion of the spiral is called the modiolus. The 
portion of the cochlea that is closest to the oval window is the base, whereas 
the portion of the cochlea that is farthest away from the oval window is the 
apex. 
The cochlea is having three compartments: scala tympani, scala 
vestibuli and   scala media.  
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The basilar membrane separates the scala tympani and the scala 
media, Reissner's membrane separates the scala media and the scala 
vestibuli  The scala tympani and the scala vestibuli  communicates with each 
other  at  helicotrema. 
In the scala media , the organ of Corti  rests on the basilar membrane. 
Basilar membrane and organ of Corti are referred to as the cochlear 
partition. 
  The organ of Corti has the inner and the outer hair cells. . 
The   inner hair cells are arranged   in a single row and   outer hair 
cells are arranged in three rows. These hair cells have hairlike projections 
called stereocilia, which is responsible for the signal transduction in hair 
cells. 
The scala vestibuli and the scala tympani are filled with perilymph, 
which resemble the extracellular fluid (high in sodium, low in potassium) in 
composition. The scala media filled with end lymph, which resemble 
intracellular fluid (low in sodium, high in potassium) in composition. The 
electrolyte composition of the scala media causes   the endocochlear 
potential, which is +60 to +100 mV relative to the perilymph.  
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PHYSIOLOGY 
 
The difference between the impedance of air and the impedance of 
fluid is great; thus, in the transmission of sound energy from Air to Fluid 
medium, there would be a 99.9% loss which is approximately 30 dB loss. 
The above loss can be overcome by impedence matching, which allows 
optimum sound energy transmission. 
.  
HYDRAULIC LEVER  
This is the ratio of the surface area of the tympanic membrane to that 
of the oval window. The tympanic membrane surface area is 55 mm2 and 
stapes foot plate surface area 3.2 mm2. This difference represents a 17-fold 
increase in surface area. Sound energy striking the much larger tympanic 
membrane is transmitted through to a much smaller surface area of the 
stapes footplate.  
 
LEVER RATIO 
The length of the manubrium, when compared the long process of the 
incus, is 1.3times longer. Hence the leverage gain is 1.3. Combined effects 
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of these two mechanisms, the Hydrualic ratio and the lever ratio ,the 
approximate gain  is 22 dB . 
 
The Two factors help in the transmission of sound energy are 
1. Optimal Eustachian tube Function 
2.  Gas exchange within the middle ear Mucosa  
 
EUSTACHIAN TUBE  
The Eustachian tube has cartilaginous and bony portion. The lateral 
bony portion of the canal opens in the anterior wall of Middle Ear. The 
medial cartilaginous part, opens into the nasopharynx and is closed at rest.  
 
The tensor veli palatini opens the Eustachian tube orifice during 
swallowing, for a transient period that lasts 0.3–0.5s.This results in pressure 
equalization with the atmospheric pressure 
 
MIDDLE EAR MUCOSAL GAS EXCHANGE  
Middle ear mucosa has a well-developed capillary structure close to 
its surface .This  helps in gas exchange In  normal conditions middle ear 
pressure is equal to  atmospheric pressure , approximately760 mmHg at sea 
level. 
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These gases are bidirectionally exchanged. Nitrogen levels in middle 
ear gas is higher than that of venous blood. This gradient results in  gas 
exchange between  the middle ear space  and  venous blood. 
The absorption of nitrogen into the venous blood results in negative 
pressure in the middle ear. This is equalized by   opening of the Eustachian 
tube. Prolonged Eustachian tube dysfunction hampers this mechanism 
results in negative middle ear pressure, transudation of fluid, and the 
development of a middle ear effusion and increases the middle ear acoustic 
impedence. 
 
TRANSMISSION OF SOUND ENERGY IN THE COCHLEA  
 
When sound energy travels through the ear, it causes the stapes 
footplate to vibrate. The vibration of the stapes footplate produces a 
compressional wave in the perilymph , which travels to  the scala vestibuli, 
through  the helicotrema, and out across the scala tympani toward the round 
window. An inward motion of the stapes results in   outward movement of 
the round window.  
When the organ of corti and basilar membrane are deflected in 
response to the compressional wave, it produces a shearing force between 
the tectorial membrane and the stereocilia of the hair cells . This shearing 
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force produces a deflection of stereocilia toward the direction of tallest row 
results in opening of stretch-sensitive cationic channels located on the 
stereocilia. The opening of these stretch-sensitive cationic channels causes a 
influx of cationic current, which results in hair cell depolarization.  
When inner hair cells are depolarized, it opens voltage-gated calcium 
channels. The resulting calcium current triggers   neurotransmitter release 
across the synapse, which results in activation of the auditory nerve fibers.  
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PATHOLOGY OF CHRONIC OTITIS MEDIA.  
Chronic otitis media is a chronic inflammation of the middle ear and 
mastoid cavity which presents with persistant  ear discharge through a 
tympanic membrane perforation , for a period of more than 3 months . 
TYPES OF CHRONIC OTITIS MEDIA . 
 
1. Chronic otitis media  mucosal type (tubotympanic). 
2. Chronic otitis media squamous type(atticoantral) 
 
STAGES OF COM 
MUCOSAL 
1. ACTIVE 
2. INACTIVE 
3. HEALED 
 
SQUAMOSAL 
1. ACTIVE 
2. INACTIVE 
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1.CHRONIC OTITIS MEDIA ACTIVE MUCOSAL TYPE  
 
 
 
This is defined as Permanent perforation of Tympanic membrane with 
inflammatory changes in the middle Ear mucosa and Mastoid and is 
characterised by mucopurulent discharge and the presence of granulation 
tissue ,Polpoidal Mucosa ,Polyp, Cholesterol granuloma , ossicular erosion . 
 
HISTOLOGY 
 
Histologic studies have shown that as the inflammatory process enters 
the chronic phase, there is a shift in cellular population from infiltrating 
leukocytes towards the mononuclear cells such as macrophages, 
lymphocytes, and plasma cells.  
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In chronic inflammation, the mucosa undergoes metaplasia from a 
single layer of cuboidal epithelium to mucosa resembling that of the 
respiratory tract with increased numbers of goblet and glandular cells. 
Consequently, there is an increase in the volume and viscosity of the mucus. 
Submucosal changes are fibrosis, hypervascularilty, infiltration of 
lymphocytes, plasma cells and histiocytes . 
 
GRANULATION TISSUE 
Granulation tissue consisting of vascular connective tissue with 
inflammatory infiltrates has been found to be the prominent pathologic 
feature of COM.As granulation tissue matures, it becomes dense and fibrotic 
with decreased vascularity. This process leads to scarring and adhesions 
associated with the ossicular chain and TM. As the inflammation persists, 
sclerosis, along with new bone formation, can cause a reduction in mastoid 
And antral pneumatization. 
 
Ossicular erosion 
Bone erosion is an important characteristic feature of Active mucosal 
and Active squamous Chronic Otitis Media. Resorptive osteitis is due to 
hyperemia with proliferation of capillaries and permanent histiocytes . 
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Following structures are eroded in descending order of frequency – long 
process of Incus ,crurae of stapes , body of incus , manubrium of mallelus .  
 
CLINICAL FEATURES 
Two hallmark presenting symptoms are  
1. otorrhea 
2. hearing loss.  
 
The nature of the otorrhea is helpful in describing the specific type of 
COM. Profuse, intermittent, non foul smelling ,mucoid discharge is 
commonly noted in chronic otitis media mucosal type. Blood-stained 
discharge is often noted with granulation tissue or polyps. 
The degree of hearing loss will depend on the size and location of the 
TM perforation and the status of the middle ear. Large perforations will 
generally cause greater hearing loss compared with smaller defects. In 
addition, perforations overlying the posterior part of the mesotympanum, 
and thus the round window niche, usually cause more severe degrees of 
conductive hearing loss because the TM is no longer protecting the round 
window membrane from direct sound energy transfer. As a result, there is 
reduction of the “baffle” effect, leading to a change in the cochlear 
mechanics. Ossicular chain involvement will also cause conductive hearing 
loss. 
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AUDIOMETRIC TESTING 
Every initial evaluation for Chronic Otitis Media should include 
audiometric testing with air and bone pure-tone thresholds. 
The degree of hearing loss isoften helpful in determining the extent of 
the middle ear disease. Perforations of the TM can account for 15 to 20 dB 
of conductive hearing loss. When perforations are accompanied by ossicular 
chain damage, the hearing loss can increase to between 30 and 50 dB. 
Speech discrimination testing is also useful. Specifically, speech reception 
thresholds can help determine whether a patient is a candidate for middle 
ear reconstructive surgery. 
 
MEDICAL MANAGEMENT 
The treatment of COM generally begins with local care of the ear and 
outpatient medical management. For medical management to be successful, 
aural toilet is imperative. The main goal is to remove debris from the EAC 
overlying the TM and middle ear cleft so that topical antimicrobial agents 
can successfully penetrate to the middle ear mucosa Topical antibiotics 
particularly  fluoroquinolones are used. 
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The addition of topical corticosteroids in combination with 
antimicrobial agents improves response rate. The anti-inflammatory 
properties of corticosteroids are thought to allow increased antibiotic levels 
in the middle ear mucosa by decreasing tissue edema Medical treatment 
usually requires 14 to 21 days. 
 
CHRONIC OTITIS MEDIA INACTIVE MUCOSAL TYPE. (Dry 
perforation). 
This is defined Permanent perforation of pars tensa without 
inflammatory changes in the middle Ear mucosa and Mastoid. Clinical 
features are only Hearing loss, without active ear discharge. On Otoscopic 
examination   Central perforation with normal Middle ear mucosa is seen. 
 
SURGICAL MANAGEMENT  
Myringoplasty-This is done under Local Anaesthesia or General 
Anaesthesia. 
Steps of Myringoplasty ; 
1. Harvesting of temporalis fascia.  
2. Transcanal exposure 
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3. Freshening the margins of perforation 
4. Canal incisions and elevation of tympanomeatal flap 
5. Assessment of ossicular chain 
6. Graft placement 
 
HARVESTING OF TEMPORALIS FASCIA 
   Temporalis fascia is a time tested material with an excellent take up 
rate because of its low metabolic rate and is available from same incision 
,ideal thickness .The fascia is elevated from the underlying temporalis 
muscle by injecting saline underneath the fascia to facilitate easy removal .  
 
FRESHENING THE MARGINS OF PERFORATION 
The margins of perforation are freshened by using sickle knife and the 
rim is removed by using cup forceps. 
 
ELEVATION OF TYMPANOMEATAL FLAP; 
 An incision is made in the bony meatal skin, starts at 12 o clock 
position superiorly and 6 o clock position inferiorly .The tympanomeatal 
flap is elevated upto fibrous annulus . The middle ear is entered using sickle 
knife.  The handle of malleus is skeletanized . 
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ASSESSMENT OF OSSICULARCHAIN; 
Ossicular continuity has to be assessed. 
 
UNDERLAY TEMPORALIS FASCIA GRAFTING; 
Temporalis fascia is placed under the remnant of tympanic membrane 
with fibrous annulus [underlay technique], and under the handle of malleus. 
 
 
Underlay technique of grafting has replaced the overlay technique due to  
1. Higher chances of lateralization of graft. 
2. Anterior blunting 
3. Longer healing time 
4. Formation of epithelial pearl  
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Associated with overlay technique. 
After grafting tympanomeatal flap is repositioned .gel foam kept around the 
flap and graft.  
 
CORTICAL MASTOIDECTOMY- 
 
EXPOSURE OF MASTOID CORTEX;  
 A modified William wilde incision is made along the post auricular 
groove. Two incisions are made over the subcutaneous tissue with the 
curvilinear vertical limb along the posterior bony canal wall close to meatal 
skin and the horizontal incision just above the spine of henle along the linea 
temporalis.  Soft tissue along with periosteum over the mastoid is elevated 
posteriorly  by lemperts periosteal elevator . The cartilaginous canal along 
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with posterior meatal skin flap is separated from its attachment at spine of 
henle by lempert periosteal elevator.  
The subcutaneous tissue over the masoid and  the posterior meatal 
skin flap is retracted by Mollison self retaining haemostatic mastoid 
retractor.  
The temporalis muscle with fascia and the subcutaneous tissue at the 
mastoid tip is retracted by Jenson mastoid retractor. 
 The important landmarks on the lateral surface of  temporal bone are  
spine of Henle , linea temporalis, and Mac Ewans triangle .  
MAC EWANSTRIANGLE; 
This is marked by linea temporalis superiorly, postero superior meatal 
wall anteriorly, a line tangential to posterior canal wall touching the linea 
temporalis posteriorly. 
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The initial drilling on mastoid cortex begins with large cutting burr 
and delineation of three boundaries of mastoid antrum. It includes 
demarcating the tegmen plate superiorly along the linea temporalis and 
posterior canal wall anteriorly; The posterior limit of dissection is variable 
and depends upon the position of lateral sinus.  
Occasionally, a partial or complete bony septum called koerner 
septum may be present in a pneumatised mastoid and it represents the 
embryonic petrosquamous junction separating the superficial squamous cells 
and deeper petrosal cells.This plate of bone is penetrated to enter the antrum. 
The mastoid antrum is often blocked with polypoidal mucosa. Once 
the polypoidal mucosa from the antrum is removed lateral semicircular 
canal, is identified.  
The exenteration of mastoid air cells involved by infected polypoidal 
mucosa, is carried out in a systematic manner which include peritegmen air 
cells, perisinus air cells, lateral and medial tip cells, sinodural cells and 
retrolabrynthine cells. 
Polypoidal mucosa or granulations blocking the aditus is removed 
.and the aditus patency checked.  
At the end of cortical mastoidectomy all the accessible cells are 
exenterated and the aditus is cleared of all the polypoidal mucosa.  
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MATERIALS AND METHODS  
MATERIAL 
Study Design- Prospective study  
Study Place- Department of ENT Stanley Medical College                                        
Chennai . 
Study Period –Jan 2012 – September   2013  
Sample size – 60 patients 
Follow up -1 Year . 
Inclusion Criteria  
• Age  15 -45 years  
• Duration of symptoms 1-5 years  
• No other foci of sepsis in the nose /paranasal sinus/nasopharynx. 
• No previous otological surgery in ear of interest.  
• Conductive hearing loss of not more than 40dB. 
• Good  cochlear  function     
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EXCLUSION CRITERIA: 
• Age   less  than  15years  , more than 45 years  
• Any foci of sepsis in nose /PNS/nasopharynx 
• Previous  otological surgery in particular ear of  interest 
• Conductive hearing loss  of more than 40 dB 
• Presence of  sensorineural   hearing  loss   
• Patient with posterosuperior Retraction or cholesteoma 
METHODOLOGY  
In our study , 60 patients were selected on the basis of Inclusion criteria 
from the period between Jan 2012 – September   2013 , and followed up for 
a period of 1 year  
 Both Males and females were taken up for the study 
 All patients between age 15 – 45 were taken into study.   
 Duration of symptoms between 1-5 years.Symptoms in either of the 
ear was taken into study. 
  Focal sepsis like tonsillitis, Adenoid enlargement, sinusitis were 
excluded by clinical examination, Diagnostic Nasal Endoscopy and 
CT Paranasal Sinus before including the patient into the study.  
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 Patients operated previously for Ear Disease, were not included in this 
study. 
 Patient with posterosuperior Retraction or cholesteoma were not 
included  
 All size of Central perforation of tympanic membrane were included. 
 Preoperatively Tuning Fork test and pure tone Audiometry were done. 
 Patient with more than 40dB were excluded from the study. 
 Patient with sensorineural hearing loss were also excluded from the 
study. 
 Patient with complications of Chronic suppurative otitis media were 
excluded from the study. 
The study was explained to the patient and the consent was taken and need 
for regular follow -up till 1 year was emphasized. 
PREOPERATIVE MANAGEMENT  
Patient with ear discharge, ear swab was taken and based on culture and 
sensitivity report topical Antibiotic Ear drops and Systemic Antibiotics were 
prescribed. 
Mucolytic agents Ambroxol was prescribed . 
Treatment was continued till the patient had no ear discharge. 
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Based on Inclusion and Exclusion criteria , 60 patients were selected  for our 
study ,out of which thirty patient were randomly selected  and subjected to 
Myringoplasty and considered as Group A .  
Myringoplasty; 
Steps ofoperaton.    
The procedure was   done under either L.A/GA  
Temporalis fascia graft was used 
Perforation‘s edge was   freshened   and undermining    done.  
Tympanomeatal flap is elevated. 
The middle ear mucosa, eustachian tube   orifice, ossicular chain status, 
presence of any granulation/cholesteatoma/retraction pocket was examined. 
Wash was given using Antibiotic solution.  
 The graft was placed under the handle of malleus in the entire patient. 
tympanomeatal meatal flap  is repositioned. 
External canal wall is packed with cotton wick soaked in antiseptic 
ointment.    
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Post Operatively Regular dressing done, Antibiotics, mucolytics were given 
for 6weeks. 
Patient was advised against taking head bath and cool drinks. 
Rest of  the Thirty patient were  subjected to Cortical mastoidectomy  with  
Type I Tympanoplasty  and considered  as Group B .  
 
CORTICAL  MASTOIDECTOMY  WITH  TYPE I TYMPANOPLASTY. 
The  procedure   was   done under either  L.A/GA . 
Temporalis fascia graft was used  in all cases. 
Tympanic membrane  perforation   edge  was  freshened  and  undermining  
done. 
Tympanomeatal flap  was elevated. 
 The middle ear  mucosa  ,eustachian  tube   orifice ,ossicular chain 
status , presence of any granulation/cholesteatoma/retraction pocket were 
examined . 
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  A Modified William Wilde  post aural incision  was made    and  
subcutaneous tissue,muscles, periosteum  are incised  and separated. 
Spine of Henle, Mac Evans triangle, posterior bony margin of meatus  
identified. Using   a  drill, mastoid  cortex is removed  over  Mac Ewans  
triangle    and   mastoid  antrum  is  identified  and  opened.  All  groups of 
diseased   air  cells were  removed  systematically  and cavity  edges were 
saucerized. Patency  of aditus  is confirmed   by  saline  irrigation. 
 The graft was placed  under the handle of malleus in all the patient . 
Tympanomeatal   flap is repositioned. 
Post aurally wound  closed  in  layers 
The  external auditory meatus  is  packed  with cotton wick soaked in 
antiseptic ointment . 
 Post Operatively regular dressing done , Antibiotics ,mucolytics were 
given for 6weeks . 
 Patient was advised against taking head bath and cool drinks . 
All patient were followed up at 2months ,6months ,1 year. 
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Patients were examined clinically and Otoscopic Examination was 
done . 
Graft take up status , presence of ear   Discharge were examined . 
Hearing was assessed using Tuning Fork test and Pure Tone 
Audiometry at 6 months and 1year   . 
1. Hearing  Improvement post operatively 
2. Graft  successfully take up 
3. No recurrence  of  disease 
Above  parameters were used to determine the successful  outcome 
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STATISTICAL ANALYSIS 
The collected data was analysed with SPSS 16.0 version. To describe 
about the data descriptive statistics frequency analysis, percentage analysis, 
mean, S.D were used. To find the significance difference between bivariate 
samples in independent samples(Myringoplasty& Cortical Mastoidectomy)  
the Independent t-test test & Mann-Whitney U test was used and for the 
paired samples (Pre OP & Post  OP) Paired t-test & Wilcoxon Signed rank 
test was used.For the  repeated measures Fried man test was used.In all the 
above statistical tools the probability value P=.05 is considered as significant 
level.  
Descriptives 
MCM = Myringoplasty 
Descriptive Statisticsa 
 
N Minimum Maximum Mean S.D 
AGE 30 17 45 30.90 8.243 
DDY 30 1 4 2.07 .907 
Valid N (listwise) 30 
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MCM = Cortical Mastoidectomy 
Descriptive Statisticsa 
 
N Minimum Maximum Mean S.D 
AGE 30 17 43 30.63 8.564 
DDY 30 1 4 2.03 .890 
Valid N (listwise) 30 
        
Frequencies 
MCM = Myringoplasty 
Frequency Table 
GENDERa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid F 19 63.3 63.3 63.3 
M 11 36.7 36.7 100.0 
Total 30 100.0 100.0   
DISEASE SIDEa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid L 15 50.0 50.0 50.0 
R 15 50.0 50.0 100.0 
Total 30 100.0 100.0   
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PERFORATION SIZEa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Large 12 40.0 40.0 40.0 
Small 18 60.0 60.0 100.0 
Total 30 100.0 100.0   
 
POST2GSa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Graft taken up 25 83.3 83.3 83.3 
Residual 
Perforation 
5 16.7 16.7 100.0 
Total 30 100.0 100.0 
  
POST2DISa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No Discharge 28 93.3 93.3 93.3 
Discharge 2 6.7 6.7 100.0 
Total 30 100.0 100.0   
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POST6GSa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Graft taken up 28 93.3 93.3 93.3 
Residual 
Perforation 
2 6.7 6.7 100.0 
Total 30 100.0 100.0   
POST6DISa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No Discharge 28 93.3 93.3 93.3 
Discharge 2 6.7 6.7 100.0 
Total 30 100.0 100.0   
POST1GSa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Graft taken up 28 93.3 93.3 93.3 
Residual 
Perforation 
2 6.7 6.7 100.0 
Total 30 100.0 100.0   
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POST1DISa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No Discharge 28 93.3 93.3 93.3 
Discharge 2 6.7 6.7 100.0 
Total 30 100.0 100.0   
MCM = Cortical Mastoidectomy 
Frequency Table 
GENDERa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid F 16 53.3 53.3 53.3 
M 14 46.7 46.7 100.0 
Total 30 100.0 100.0   
DISEASESIDEa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid L 15 50.0 50.0 50.0 
R 15 50.0 50.0 100.0 
Total 30 100.0 100.0   
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PERFORATIONSIZEa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Large 13 43.3 43.3 43.3 
Small 17 56.7 56.7 100.0 
Total 30 100.0 100.0   
POST2GSa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Graft taken up 26 86.7 86.7 86.7 
Residual 
Perforation 
4 13.3 13.3 100.0 
Total 30 100.0 100.0   
POST2DISa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No Discharge 29 96.7 96.7 96.7 
Discharge 1 3.3 3.3 100.0 
Total 30 100.0 100.0   
 
 50 
 
POST6GSa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Graft taken up 28 93.3 93.3 93.3 
Residual 
Perforation 
2 6.7 6.7 100.0 
Total 30 100.0 100.0   
POST6DISa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No Discharge 28 93.3 93.3 93.3 
Discharge 2 6.7 6.7 100.0 
Total 30 100.0 100.0   
POST1GSa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Graft taken up 28 93.3 93.3 93.3 
Residual 
Perforation 
2 6.7 6.7 100.0 
Total 30 100.0 100.0   
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POST1DISa 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No Discharge 28 93.3 93.3 93.3 
Discharge 2 6.7 6.7 100.0 
Total 30 100.0 100.0   
 
T-Test 
MCM = 
Myringoplasty 
Paired Samples Statisticsa 
 Pair 1 
 Mean N 
Std. 
Deviation 
Std. Error 
Mean 
 
 
HLPRE 27.83 30 4.086 .746 
HLPOST 18.50 30 5.894 1.076 
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Paired  
Samples Testa 
 
 Paired Differences Pair 1 
HLPRE - 
HLPOST 
 
T 
Df 
Mean 9.333 
Std. Deviation 3.651 
Std. Error Mean .667 
95% 
Confidence 
Interval of the 
Difference 
Lower 7.970 
Upper 10.697 
Sig. (2-tailed) 14.000 
29 
.000 
MCM = Cortical 
Mastoidectomy 
Paired Samples Statisticsa 
 Pair 1 
 Mean N 
Std. 
Deviation 
Std. Error 
Mean 
 
 
HLPRE 31.83 30 4.997 .912 
HLPOST 22.17 30 5.032 .919 
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Paired Samples 
Testa 
 
 Paired Differences Pair 1 
HLPRE - 
HLPOST 
 
T 
Df 
Mean 9.667 
Std. Deviation 4.536 
Std. Error Mean .828 
95% 
Confidence 
Interval of the 
Difference 
Lower 7.973 
Upper 11.360 
Sig. (2-tailed) 11.673 
29 
.000 
  
  
T-Test 
Group Statistics 
  
DDY 
 MCM
HLPRE Myringoplasty
Cortical 
Mastoidectomy
HLPOST Myringoplasty
Cortical 
Mastoidectomy
 Myringoplasty
Cortical 
Mastoidectomy
 
27.83
Pre OP
Myringoplasty
54 
 N Mean 
 30 2.07 
 
30 2.03 
 30 27.83 
 
30 31.83 
 30 18.50 
 
30 22.17 
18.5
31.83
22.17
Post OP
Hearing Loss in db
Cortical Mastoidectomy
Std. 
Deviation 
Std. Error 
Mean 
.907 .166 
.890 .162 
4.086 .746 
4.997 .912 
5.894 1.076 
5.032 .919 
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Independent Samples Test 
 
Levene's 
Test for 
Equality 
of 
Variance
s t-test for Equality of Means 
F 
Sig
. t df 
Sig. 
(2-
taile
d) 
Mean 
Differ
ence 
Std. 
Error 
Differ
ence 
95% 
Confiden
ce 
Interval 
of the 
Differenc
e 
Lo
wer 
Up
per 
DDY Equal 
varian
ces 
assum
ed 
.08
7 
.76
9 
.144 58 .886 .033 .232 -
.43
1 
.49
8 
Equal 
varian
ces 
not 
assum
ed 
    
.144 57.
979 
.886 .033 .232 -
.43
1 
.49
8 
HLPR
E 
Equal 
varian
ces 
assum
ed 
1.8
74 
.17
6 
-
3.39
4 
58 .001 -4.000 1.179 -
6.3
59 
-
1.6
41 
Equal 
varian
ces 
not 
assum
ed 
    
-
3.39
4 
55.
799 
.001 -4.000 1.179 -
6.3
61 
-
1.6
39 
HLPO
ST 
Equal 
varian
ces 
assum
ed 
.27
9 
.60
0 
-
2.59
1 
58 .012 -3.667 1.415 -
6.4
99 
-
.83
4 
Equal 
varian
ces 
not 
assum
ed 
    
-
2.59
1 
56.
606 
.012 -3.667 1.415 -
6.5
00 
-
.83
3 
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NPar 
Tests 
MCM = 
Myringoplasty 
Friedman Test 
Ranksa 
 
Mean 
Rank 
POST2
GS 
2.10 
POST6
GS 
1.95 
POST1
GS 
1.95 
Test Statisticsa,b 
N 30 
Chi-
Square 
6.000 
df 2 
Asymp. 
Sig. 
.050 
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MCM = Cortical 
Mastoidectomy 
Friedman Test 
Ranksa 
 
Mean 
Rank 
POST2
GS 
2.07 
POST6
GS 
1.97 
POST1
GS 
1.97 
Test Statisticsa,b 
N 30 
Chi-
Square 
4.000 
df 2 
Asymp. 
Sig. 
.135 
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NPar 
Tests 
MCM = 
Myringoplasty 
Friedman Test 
Ranksa 
 
Mean 
Rank 
POST2
DIS 
2.00 
POST6
DIS 
2.00 
POST1
DIS 
2.00 
Test Statisticsa,b 
N 30 
Chi-
Square 
. 
df 2 
Asymp. 
Sig. 
. 
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MCM = Cortical 
Mastoidectomy 
Friedman Test 
Ranksa 
 
Mean 
Rank 
POST2
DIS 
1.97 
POST6
DIS 
2.02 
POST1
DIS 
2.02 
Test Statisticsa,b 
N 30 
Chi-
Square 
2.000 
df 2 
Asymp. 
Sig. 
.368 
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NPar 
Tests 
MCM = 
Myringoplasty 
Wilcoxon Signed Ranks 
Test 
Rankss 
 N 
Mean 
Rank 
Sum of 
Ranks 
POST6
GS - 
POST2
GS 
Negative 
Ranks 
3 2.00 6.00 
Positive 
Ranks 
0 .00 .00 
Ties 27     
Total 30     
POST1
GS - 
POST2
GS 
Negative 
Ranks 
3 2.00 6.00 
Positive 
Ranks 
0 .00 .00 
Ties 27     
Total 30     
POST1 Negative 0 .00 .00 
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GS - 
POST6
GS 
Ranks 
Positive 
Ranks 
0 .00 .00 
Ties 30     
Total 30     
POST6
DIS - 
POST2
DIS 
Negative 
Ranks 
0 .00 .00 
Positive 
Ranks 
0 .00 .00 
Ties 30     
Total 30     
POST1
DIS - 
POST2
DIS 
Negative 
Ranks 
0 .00 .00 
Positive 
Ranks 
0 .00 .00 
Ties 30     
Total 30     
POST1
DIS - 
POST6
DIS 
Negative 
Ranks 
0 .00 .00 
Positive 
Ranks 
0 .00 .00 
Ties 30     
Total 30     
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Test Statisticsc,d 
 
Z 
Asymp. 
Sig. (2-
tailed) 
POST6GS 
- 
POST2GS 
-1.732 .083 
POST1GS 
- 
POST2GS 
-1.732 .083 
POST1GS 
- 
POST6GS 
.000 1.000 
POST6DIS 
- 
POST2DIS 
.000 1.000 
POST1DIS 
- 
POST2DIS 
.000 1.000 
POST1DIS 
- 
POST6DIS 
.000 1.000 
MCM = Cortical Mastoidectomy 
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Wilcoxon Signed Ranks Test 
Rankss 
 N 
Mean 
Rank 
Sum of 
Ranks 
POST6GS 
- 
POST2GS 
Negative 
Ranks 
2 1.50 3.00 
Positive Ranks 0 .00 .00 
Ties 28     
Total 30     
POST1GS 
- 
POST2GS 
Negative 
Ranks 
2 1.50 3.00 
Positive Ranks 0 .00 .00 
Ties 28     
Total 30     
POST1GS 
- 
POST6GS 
Negative 
Ranks 
0 .00 .00 
Positive Ranks 0 .00 .00 
Ties 30     
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Total 30     
POST6DIS 
- 
POST2DIS 
Negative 
Ranks 
0 .00 .00 
Positive Ranks 1 1.00 1.00 
Ties 29     
Total 30     
POST1DIS 
- 
POST2DIS 
Negative 
Ranks 
0 .00 .00 
Positive Ranks 1 1.00 1.00 
Ties 29     
Total 30     
POST1DIS 
- 
POST6DIS 
Negative 
Ranks 
0 .00 .00 
Positive Ranks 0 .00 .00 
Ties 30     
Total 30     
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Test Statisticsd,e 
 
Z 
Asymp. 
Sig. (2-
tailed) 
POST6GS 
- 
POST2GS 
-1.414 .157 
POST1GS 
- 
POST2GS 
-1.414 .157 
POST1GS 
- 
POST6GS 
.000 1.000 
POST6DIS 
- 
POST2DIS 
-1.000 .317 
POST1DIS 
- 
POST2DIS 
-1.000 .317 
POST1DIS 
- 
POST6DIS 
.000 1.000 
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NPar Tests 
Mann-Whitney Test 
Ranks 
  
MCM N 
Mean 
Rank 
Sum of 
Ranks 
POST2GS Myringoplasty 30 31.00 930.00 
Cortical 
Mastoidectomy 
30 30.00 900.00 
Total 60     
POST2DIS Myringoplasty 30 31.00 930.00 
Cortical 
Mastoidectomy 
30 30.00 900.00 
Total 60     
POST6GS Myringoplasty 30 30.50 915.00 
Cortical 
Mastoidectomy 
30 30.50 915.00 
Total 60     
POST6DIS Myringoplasty 30 30.50 915.00 
Cortical 
Mastoidectomy 
30 30.50 915.00 
Total 60     
POST1GS Myringoplasty 30 30.50 915.00 
Cortical 
Mastoidectomy 
30 30.50 915.00 
Total 60     
POST1DIS Myringoplasty 30 30.50 915.00 
Cortical 
Mastoidectomy 
30 30.50 915.00 
Total 60     
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Test Statisticsa 
 
Mann-Whitney 
U 
Wilcoxon 
W Z 
Asymp. 
Sig. (2-
tailed) 
POST2GS 435.000 900.000 -.359 .720 
POST2DIS 435.000 900.000 -.587 .557 
POST6GS 450.000 915.000 .000 1.000 
POST6DIS 450.000 915.000 .000 1.000 
POST1GS 450.000 915.000 .000 1.000 
POST1DIS 450.000 915.000 .000 1.000 
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RESULTS AND OBSERVATION  
Totally 60 patients were included in our study. 
Out of which 30 patients were randomly selected in Group A and underwent 
Myringoplasty . 
Rest of the patients, were included in Group B , underwent Cortical 
Mastoidectomy with Type I Tympanoplasty . 
PREOPERATIVE STATUS 
Group A –  
In this group , 19 were Female , 11 were Male patients . 
18 patients had small Perforation, while 12patients had Large central 
perforation of the tympanic membrane. 
Pre op Hearing loss in group A – 27.8 dB . 
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POST OPERATIVE STATUS 
GRAFT UPTAKE STATUS 
At 2 months, 
Graft taken up in 25 patients, 5 patients had residual perforation which 
corresponds to success rate of 83.3 % of Graft uptake. 
At 6 months, 
Totally, 28 patients had graft uptake, while only 2 patients had residual  
perforation which corresponds to success rate of  93.3 % of Graft uptake . 
At the end of 1 year, 
Totally, 28 patients had graft uptake, while only 2 patients had persistent 
perforation, which corresponds to success rate of 93.3 % of Graft uptake. 
DISCHARGE STATUS 
28 patients had no discharge, from 2 months till the end of 1 year. 
Only 2 patients, out of 30 patients had persistent discharge, till the end of 1 
year , without improvement . Success Rate is 93.3 %. 
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HEARING STATUS 
Preoperatively patient had a average of 27.8 dB of Hearing loss. 
Hearing was tested by Pure tone audiometry, which showed, Hearing loss 
has reduced to 18.5 dB. 
So, 9.3dB of Hearing gain has been achieved. 
 
PREOPERATIVE STATUS 
Group B –  
In this group , 16 were Female , 14 were Male patients . 
17 patients had small Perforation, while 13 patients had Large central 
perforation of the tympanic membrane. 
Pre op Hearing loss in group B – 31.83dB. 
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POSTOPERATIVE STATUS 
GRAFT UPTAKE STATUS 
At 2 months , 
Graft  taken up in 26 patients ,4 patients had residual perforation which 
corresponds to success rate of  86.7 % of Graft uptake . 
 
At 6 months , 
Totally , 28 patients had graft uptake , while only 2 patients had residual  
perforation which corresponds to success rate of  93.3 % of Graft uptake . 
 
At the end of 1 year , 
Totally , 28 patients had graft uptake , while only 2 patients had persistent  
perforation,which corresponds to success rate of  93.3 % of Graft uptake. 
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DISCHARGE STATUS 
29 patients had no discharge ,at 2 months 
  1 patient had discharge at the end of 2 months. 
At the end of 1 year ,only  2 patients ,out of 30 patients had persistent 
discharge . 
Success Rate is 93.3 %. 
Hearing status 
Preoperatively patient had a average of 31.83 dB of Hearing loss. 
Hearing was tested by Pure tone audiometry, which showed, Hearing loss 
has reduced to 22.17 dB. 
So, 9.66 dB of Hearing gain has been achieved. 
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DISCUSSION 
The post operative outcome  in Group A patients ,who underwent  
Myringoplasty  and Group B patients ,who underwent  Cortical 
Mastoidectomy  has been compared . 
Hearing status – In Group A patients, the hearing loss is reduced to 18.5 dB 
,from the preoperative hearing loss of 27.8dB . 
So the hearing gain is 9.3dB. 
In Group B patients , the hearing loss is reduced to 22.1dB ,from the 
preoperative hearing loss of 31.8dB . 
Here , the hearing gain is 9.7dB. 
When comparing both the results , the difference of hearing gain between 
these two surgical procedures ,is insignificant. 
Graft uptake status – 
In Group A patients ,the graft uptake success rate is 83.3 % at 2months , 
93.3 % at 6 months and 1 year . 
,In Group B patients ,the graft uptake success rate is 86.7 % at 2months , 
93.3 % at 6 months and 1 year . 
Statistically , the difference in the outcome is insignificant. 
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Discharge status – 
In Group A, 93.3 % patients had no ear discharge, upto the follow up period 
of 1 year. 
While in Group B patients, same percentage of success rate is seen . 
So statistically, there is no difference between these procedures. 
Therefore, above results showed that  clinically and statistically cortical 
Mastoidectomy with Type I Tympanoplasty had no added advantage over 
Myringoplasty in the surgical outcome  of active cases of Chronic Otitis 
Media. 
Results of our study are compared with similar studies available in literature. 
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STUDY 1 
Study conducted by Albus,TranbalziniF,Amadori ,Department  of  
otorhinolarynogology , Clauj,Napoca 
Romania . 
 
In this study , Total No. of patient – 320  
 No . of Cases  Success Rate Failure Rate   
Group A 160 82.8% 17.2% 
 
Group B  160 76%  24% 
 
Group A – Cortical Mastoidectomy with Type I Tympanoplasty 
 
Group B – Myringoplasty 
 
Totally 320 patients were taken for the study , all the patient were in Active 
mucosal stage of Chronic Otitis media , Graft Take Up and recurrence of 
discharge  were compared . The success rate in Group  A was – 82.8%, 
where as in Group B , it was 76% . 
Statistically , the difference is insignificant . 
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STUDY 2 
.The study conducted by Mishiro Y, Kitahara T, Takahashi Y, ,Kajikawa, 
Sakagami 
 
In this study , Total No. of patient – 251  
 No . of Cases  Success Rate Failure Rate   
Group A 147 91% 9% 
 
Group B  104 94%  6% 
 
Group A – Cortical Mastoidectomy with Type I Tympanoplasty 
Group B – Myringoplasty 
 
Totally 251 patients were taken for the study , all the patient were in Active 
mucosal stage of Chronic Otitis media , Graft Take Up and recurrence of 
discharge  were compared . The success rate in Group  A was – 91%, where 
as in Group B , it was 94% . 
 
Statistically , the difference is insignificant . 
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STUDY 3 
 
The study conducted by Balyan FR, , Asian A, Taibah A, Sanna, Celikkanat 
S, Russo A, 
In this study, Total No. of patient – 81 
 No. of Cases  Success Rate Failure Rate   
Group A 28 86% 14% 
 
Group B  53 91%  9% 
 
Group A – Cortical Mastoidectomy with Type I Tympanoplasty 
 
Group B – Myringoplasty 
 
Totally 81 ,patients were taken for the study , all the patient were in Active 
mucosal stage of Chronic Otitis media , Graft Take Up and recurrence of 
discharge  were compared . The success rate in Group  A was – 86%, where 
as in Group B , it was 91% . 
 
Statistically , the difference is insignificant . 
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STUDY 4 
 
The study conducted by Bhat K,Hedge J S  
 
NagalotimathKumar ,Naseeruddin 
 
 
In this study , Total No. of patient – 68 
 No . of Cases  Success Rate Failure Rate   
Group A 35 90% 10% 
 
Group B  33 91%  9% 
 
Group A – Cortical Mastoidectomy with Type I Tympanoplasty 
 
Group B – Myringoplasty 
 
Totally 68 ,patients were taken for the study , all the patient were in Active 
mucosal stage of Chronic Otitis media , Graft Take Up,Hearing 
Improvement  and recurrence of discharge  were compared . The success 
rate in Group A was – 90%, where as in Group B , it was 91% . 
 
Statistically, the difference is insignificant. 
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The results of the all the above studies , showed that there is no 
statistically significant difference  in the success rate of Graft Uptake 
,Hearing Improvement and recurrence Rate between Myringoplasty and 
Cortical Mastoidectomy with Type I Tympanoplasty . 
 
These results Coincides with our study results that Cortical 
Mastoidectomy ,doesnot influence much on the success rate of Graft Uptake 
,Hearing Improvement and recurrence Rate,when compared with 
Myringoplasty Alone . 
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CONCLUSION 
In our study, the results prove that in patients with chronic otitis Media 
,tubotympanic type ,Active Disease , 
Myringoplasty and cortical Mastoidectomy with type I tympanoplasty ,has 
similar surgical outcome ,in terms of Hearing gain ,Recurrence of the 
disease , graft uptake  provided that patients  are selected carefully. 
 
CONCLUSIONS 
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LIMITATIONS OF THE STUDY  
1. Since the Study Group is very small in our study, only approximate    
statistical inference could be obtained. 
2. The period of follow up  is short ,so later recurrence could be 
missed. 
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PROFORMA 
Case no:        
Name :       Address: 
Age :        IP no : 
Sex: 
Occupation: 
Presenting complaints:    Side    Duration 
Ear Discharge  
Hard of Hearing  
Ear pain  
Tinnitus  
Giddiness  
History of presenting illness 
Ear discharge – Side  
 Duration 
 Onset  
Type 
 Quantity  
Continous/Intermittent  
Aggravating /Relieving factor 
Hard of hearing  
Side   
Duration  
Onset  
Progression  
Ear Pain   
Side  
Duration 
Intensity 
Aggravating/Relieving Factors  
Nasal Complaints  
Nasal Block /Nasal Discharge/Headache  
Throat Complaints  
Throat Pain ,Difficulty in swallowing  
 
Past History  
Any previous of Surgery  
Any H/o DM /Hypertension /TB/Asthma/CAD/Epilepsy  
Any H/o Drug Allergy/Bleeding Diathesis. 
Family History: 
Any similar illness in the family. 
General Physical Examination: 
Built /Nutrition /Febrile/Anemia/Jaundice/Cyanosis/generalized  
Lymphadenopathy. 
Systemic Examination – CVS/RS/PA/CNS 
ENT Examination  
Examination of the Ear    Right   Left  
Preauricular Region  
Pinna 
Postauricular Region  
External Auditory Canal  
Tympanic Membrane 
Middle Ear Status  
Tuning Fork tests  
Rinnes test  
Weber test  
Absolute Bone Conduction test  
Tragus sign  
Fistula test  
Three point Mastoid tenderness  
Facial Nerve Examination  
 
Examination of Nose  
External Nose  
Dorsum  
Ala 
Columella 
Anterior Rhinoscopy                Right     Left  
Septum  
Inferior Turbinate  
Inferior Meatus  
Middle Turbinate  
Middle Meatus  
Cottles Test  
Cold spatula Test  
Cotton Wool test  
Paranasal Sinus Tenderness  
 
Examination of Throat  
Lips /teeth /gums/Tongue /Hard Palate / 
 Soft palate/Uvula/Tonsil/Anterior and Posterior Pillar /Posterior pharyngeal Wall . 
 
Provisional Diagnosis  
Investigation  
1.Pure Tone Auditory  
2. X –ray Mastoid 
3. Diagnostic Nasal Endoscopy  
4.CT  PNS 
 
Management  
Medical Management  
Surgical Management  
1. Myringoplasty 
2. Cortical Mastoidectomy with Type I Tympanoplasty . 
 
Post operative follow up 
     2months   6 months  1 year  
Otoscopic Examination  
Tuning Fork Test  
Pure Tone Audiometry   
  
 
 

 


